Ionis Pharmaceuticals Insider Trades

IONS

Track insider trading activity from Ionis Pharmaceuticals executives and directors. See which insiders are buying and selling IONS stock.

Trades Last 12 Months

IONS Price

All Insider Trades for Ionis Pharmaceuticals

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Monia Brett P Chief Executive Officer
Holding Value $2.63M 35,637 shares
Last Trade
May 14, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$244k 3,220 shares
$75.68
$73.82
Loscalzo Joseph Director
Holding Value $0 0 shares
Last Trade
May 04, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$905k 12,000 shares
$75.45
$73.82
Klein Joseph Iii Director
Holding Value $0 0 shares
Last Trade
May 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$761k 10,111 shares
$75.28
$73.82
Baroldi Joseph Evp, Chief Business Officer
Holding Value $3.32M 44,909 shares
Last Trade
Apr 28, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$117k 1,626 shares
$71.79
$73.82
Jenne Kyle Evp, Chf GL Pdt Str Ofcr
Holding Value $1.75M 23,713 shares
Last Trade
Apr 16, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$368k 4,902 shares
$75.17
$73.82
Birchler Brian Evp, Corp And Development Ops
Holding Value $4.98M 67,500 shares
Last Trade
Apr 16, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$73k 973 shares
$75.04
$73.82
Parshall B Lynne Director
Holding Value $3.83M 51,878 shares
Last Trade
Apr 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$340k 4,466 shares
$76.19
$73.82
Devers Shannon L. Evp, Chief Human Resources Ofc
Holding Value $1.21M 16,348 shares
Last Trade
Apr 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$459k 6,193 shares
$74.05
$73.82
Schneider Eugene Evp, Chf Clinical Develop Ofcr
Holding Value $4.72M 63,890 shares
Last Trade
Mar 19, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$412k 5,812 shares
$70.97
$73.82
Hougen Elizabeth L Evp, Finance & CFO
Holding Value $6.1M 82,660 shares
Last Trade
Mar 17, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$745k 10,172 shares
$73.21
$73.82
Diaz Allene M. Director
Holding Value $4.33M 58,689 shares
Last Trade
Mar 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.17M 40,321 shares
$78.66
$73.82
Bennett C Frank Evp, Chief Scientific Officer
Holding Value $12.2M 165,643 shares
Last Trade
Mar 03, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.82M 48,626 shares
$78.66
$73.82
O'neil Patrick R. EVP CLO & General Counsel
Holding Value $5.34M 72,359 shares
Last Trade
Feb 27, 2026 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$30.5k 376 shares
$81.15
$73.82
Swayze Eric EVP Research
Holding Value $2.39M 32,361 shares
Last Trade
Feb 27, 2026 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$20.8k 256 shares
$81.15
$73.82
Kordasiewicz Holly B. Evp, Chief Development Officer
Holding Value $1.09M 14,718 shares
Last Trade
Jan 16, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$313k 4,141 shares
$75.66
$73.82
Yang Michael J. Director
Holding Value $586k 7,940 shares
Last Trade
Jan 15, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$149k 1,930 shares
$77.21
$73.82
Wender Joseph H Director
Holding Value $3.21M 43,464 shares
Last Trade
Dec 01, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.66M 20,571 shares
$80.67
$73.82
Herman Joan E Director
Holding Value $4.29M 58,086 shares
Last Trade
Nov 19, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$888k 12,000 shares
$74.00
$73.82
Geary Richard S Evp, Chief Development Officer
Holding Value $0 0 shares
Last Trade
Nov 06, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.45M 33,038 shares
$74.10
$73.82
O'neil Patrick R. EVP CLO & General Counsel
Holding Value $1.25M 17,000 shares
Last Trade
Oct 06, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$704k 10,200 shares
$69.04
$73.82

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up